Hearing Loss
Hearing Loss is an ENT-related condition involving reduced or impaired hearing. Research described for this condition addresses different outcomes, including tinnitus-related difficulty and possible protection against certain drug-related effects on hearing.
Hearing Loss is an ENT-related condition covered in this wellness reference.
This list shows research findings, not treatments. Nothing here replaces medical care. If you have this condition, talk to a doctor.
What may help
None of these options has good evidence yet. Best evidence first.
2 options:1 not enough evidence1 no benefit found
PsychotherapypracticeNot enough evidence
Too few or too small studies to know if it works.
The one study found a benefit.
A randomized trial in 100 deaf women found improvement in primary and secondary outcomes compared with routine services.
Open the Psychotherapy pageRed Light Therapy (Photobiomodulation)practiceNo benefit found
Studies looked for a benefit and did not find one.
The one study found no benefit.
The studies did not support a general benefit for hearing loss: a 2025 review found audiometric improvements mainly in moderate hearing loss, with minimal changes in severe cases.
Open the Red Light Therapy (Photobiomodulation) page
May not suit people with this condition
Supplements and practices linked to problems for people with this condition.
Ear CandlingpracticeUnclear
New or unexplained hearing loss needs medical evaluation; ear candling may obstruct the canal or cause thermal injury, and could delay diagnosis of an urgent ear condition.
Open the Ear Candling page
The expert view shows every study, dose protocol and source.
What may help
Interventions recorded as helping with this condition2 listedThe best we have, but the evidence is still weak
- →PracticesPsychotherapyCertaintyLowSourceClinical
A randomized trial in 100 deaf women found improvement in primary and secondary outcomes compared with routine services.
Who was studied
- People with a condition
- Hearing Loss
Open PsychotherapyStudy result
Primary and secondary outcomes improved versus routine services in deaf women; single RCT.
Very low probability(1)
- →PracticesRed Light Therapy (Photobiomodulation)CertaintyVery lowSourceClinical
The studies did not support a general benefit for hearing loss: a 2025 review found audiometric improvements mainly in moderate hearing loss, with minimal changes in severe cases.
Open Red Light Therapy (Photobiomodulation)Who was studied
- People with a condition
- Hearing Loss
- Tinnitus
What to avoid
Interventions recorded as making it worse1 listedHighest probability
- →PracticesEar CandlingCertaintyLowSourceReference knowledge
New or unexplained hearing loss needs medical evaluation; ear candling may obstruct the canal or cause thermal injury, and could delay diagnosis of an urgent ear condition.
Open Ear CandlingRationale
New or unexplained hearing loss should be medically evaluated rather than treated with ear candling, which can obstruct the canal, cause thermal injury, and delay diagnosis of potentially urgent ear disease.
How to read the evidence
Evidence tier — overall strength of the evidence for the whole compound
- StrongWell established — backed by strong, consistent human research.
- ModerateSome genuine support, but mostly from small or lower-quality studies. Promising, not proven.
- PreliminaryEarly-stage evidence — a promising hypothesis, not an established effect yet.
- LimitedVery limited evidence — treat this as a hypothesis, not proof.
- InsufficientNot enough good evidence to draw conclusions yet.
Certainty — how sure we can be that the effect is real
- Very highVery sure — strong, consistent evidence
- HighFairly sure — consistent evidence from good studies
- MediumModerately sure — new studies could change this
- LowNot sure — little or mixed evidence
- Very lowVery unsure — almost no usable evidence
Source — where the data comes from
- Meta-analysisPooled analysis of many trials — the strongest evidence
- RCTRandomized controlled trial — a strong human study design
- ClinicalA human clinical study
- Reference knowledgeFrom general health-science or pharmacology references, not a study of this exact claim
- Animal researchStudied in animals, not humans
- Community reportsAggregated user reports — anecdotal signal, not evidence
- TheoreticalMechanism-based reasoning, not yet tested
Study grade — quality of each underlying study (A best, D weakest)
- AHigh-quality — strong, consistent human trials
- BGood — solid evidence with some limitations
- CModerate — limited, small, or mixed-quality studies
- DWeak — preliminary, indirect, or animal-only
Confidence — how strongly the sources back a finding
A 0–100 score from study quality and agreement
Most supplement evidence is graded C–D. Read it as preliminary signal, not proof.
Full write-up
What is it
Hearing Loss is an ENT-related condition involving reduced or impaired hearing. Research described for this condition addresses different outcomes, including tinnitus-related difficulty and possible protection against certain drug-related effects on hearing. These outcomes are not interchangeable, so findings involving one aspect should not automatically be interpreted as evidence for all forms or causes of hearing loss.
Evidence-backed options
The options associated with Hearing Loss do not all address the same outcome. Ginkgo Biloba has a clinical finding involving reduction and improvement of tinnitus handicap with Equitam®/EGb 761, but tinnitus handicap is not identical to hearing loss. This makes the relevance of that finding dependent on the symptoms and cause being considered.
Melatonin has been examined in animal research for protection against the ototoxic effects of cisplatin and aminoglycosides. The reported protection involved the frequencies 5000 Hz, 6000 Hz, and 8000 Hz. This is preclinical evidence and does not establish an effect for hearing loss in people.
Acetyl-L-Carnitine (ALCAR) was studied through systemic administration in Fischer 344/NHsd rats with age-related hearing loss. That study did not provide evidence that the condition could be altered. Together, these findings leave important limits around how broadly the options apply, particularly when the cause of hearing loss, the person’s health status, and whether tinnitus is also present differ from the settings studied.
No dose, treatment duration, or time to onset of an effect is established in these findings. The evidence is therefore better understood as condition- and outcome-specific rather than as support for a general approach to Hearing Loss. A clinician can help interpret these options in the context of the type and cause of hearing loss.
What to avoid
Ear Candling is flagged because new or unexplained hearing loss requires medical evaluation rather than an ear-candling approach. Using it may obstruct the ear canal or cause thermal injury, potentially adding harm while the underlying problem remains unassessed.
A further concern is delayed diagnosis of potentially urgent ear disease. For hearing loss that is new or unexplained, evaluation by a clinician is important before considering approaches that could interfere with examination or treatment.